BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34173712)

  • 1. LINC01234 aggravates cell growth and migration of triple-negative breast cancer by activating the Wnt pathway.
    Xiao F; Jia H; Wu D; Zhang Z; Li S; Guo J
    Environ Toxicol; 2021 Oct; 36(10):1999-2012. PubMed ID: 34173712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-6838-5p suppresses cell metastasis and the EMT process in triple-negative breast cancer by targeting WNT3A to inhibit the Wnt pathway.
    Liu G; Wang P; Zhang H
    J Gene Med; 2019 Dec; 21(12):e3129. PubMed ID: 31693779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA linc00921 suppresses tumorigenesis and epithelial-to-mesenchymal transition of triple-negative breast cancer via targeting miR-9-5p/LZTS2 axis.
    Zhang J; Zhang L; Wang J; Zhao J; Zhao X; Zhang C; Han P; Geng C
    Hum Cell; 2022 May; 35(3):909-923. PubMed ID: 35179718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA SNHG8 enhances triple-negative breast cancer cell proliferation and migration by regulating the miR-335-5p/PYGO2 axis.
    Qian J; Lei X; Sun Y; Zheng L; Li J; Zhang S; Zhang L; Li W; Shi J; Jia W; Tang T
    Biol Direct; 2021 Aug; 16(1):13. PubMed ID: 34362407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTCF-Induced lncRNA C5orf66-AS1 Facilitates the Progression of Triple-Negative Breast Cancer via Sponging miR-149-5p to Up-Regulate CTCF and CTNNB1 to Activate Wnt/β-Catenin Pathway.
    Zhu S; Sun J; Liu X; Shao H; Feng C; Wang Z; Zheng X; Wei S
    Mol Cell Biol; 2022 Jun; 42(6):e0018821. PubMed ID: 35499320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA DLX6-AS1 Contributes to Epithelial-Mesenchymal Transition and Cisplatin Resistance in Triple-negative Breast Cancer via Modulating Mir-199b-5p/Paxillin Axis.
    Du C; Wang Y; Zhang Y; Zhang J; Zhang L; Li J
    Cell Transplant; 2020; 29():963689720929983. PubMed ID: 32686982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MYBL2-induced PITPNA-AS1 upregulates SIK2 to exert oncogenic function in triple-negative breast cancer through miR-520d-5p and DDX54.
    Liu B; Yao P; Xiao F; Guo J; Wu L; Yang Y
    J Transl Med; 2021 Aug; 19(1):333. PubMed ID: 34353336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA LINC01234 silencing exerts an anti-oncogenic effect in esophageal cancer cells through microRNA-193a-5p-mediated CCNE1 downregulation.
    Ma J; Han LN; Song JR; Bai XM; Wang JZ; Meng LF; Li J; Zhou W; Feng Y; Feng WR; Ma JJ; Hao JT; Shen ZQ
    Cell Oncol (Dordr); 2020 Jun; 43(3):377-394. PubMed ID: 32130660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA SOX21-AS1 regulates the progression of triple-negative breast cancer through regulation of miR-520a-5p/ORMDL3 axis.
    Liu X; Song J; Kang Y; Wang Y; Chen A
    J Cell Biochem; 2020 Nov; 121(11):4601-4611. PubMed ID: 32277517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA LINC01234 promoted cell proliferation and invasion via miR-1284/TRAF6 axis in colorectal cancer.
    Liao X; Zhan W; Zhang J; Cheng Z; Li L; Tian T; Yu L; Li R
    J Cell Biochem; 2020 Oct; 121(10):4295-4309. PubMed ID: 31904146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR-219a-5p.
    Wang L; Luan T; Zhou S; Lin J; Yang Y; Liu W; Tong X; Jiang W
    Cancer Med; 2019 Aug; 8(9):4389-4403. PubMed ID: 31215169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis.
    Wang R; Huang Z; Qian C; Wang M; Zheng Y; Jiang R; Yu C
    Biochem Biophys Res Commun; 2020 Jun; 526(4):1005-1012. PubMed ID: 32307083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis.
    Han C; Fu Y; Zeng N; Yin J; Li Q
    Aging (Albany NY); 2020 Feb; 12(4):3594-3616. PubMed ID: 32074085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-221/222 activate the Wnt/β-catenin signaling to promote triple-negative breast cancer.
    Liu S; Wang Z; Liu Z; Shi S; Zhang Z; Zhang J; Lin H
    J Mol Cell Biol; 2018 Aug; 10(4):302-315. PubMed ID: 30053090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p.
    Li S; Zhou J; Wang Z; Wang P; Gao X; Wang Y
    Biomed Pharmacother; 2018 Aug; 104():451-457. PubMed ID: 29793177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Non-coding RNA LINC01224 Promotes the Malignant Behaviors of Triple Negative Breast Cancer Cells via Regulating the miR-193a-5p/NUP210 Axis.
    Sang K; Yi T; Pan C; Zhou J; Yu L
    Mol Biotechnol; 2023 Apr; 65(4):624-636. PubMed ID: 36127622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-296-3p inhibits cell proliferation by the SOX4-Wnt/βcatenin pathway in triple-negative breast cancer.
    Tian D; Luo L; Wang T; Qiao J
    J Biosci; 2021; 46():. PubMed ID: 34785625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LINC01234 Accelerates the Progression of Breast Cancer via the miR-525-5p/Cold Shock Domain-Containing E1 Axis.
    Yu J; Zhang X; He R; Yang X; Hu J; Tan F; Yao J; Lei X; Wen G
    Dis Markers; 2022; 2022():6899777. PubMed ID: 35923244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TCF3-activated FAM201A enhances cell proliferation and invasion via miR-186-5p/TNKS1BP1 axis in triple-negative breast cancer.
    Jia H; Wu D; Zhang Z; Li S
    Bioorg Chem; 2020 Nov; 104():104301. PubMed ID: 33011533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long Noncoding RNA LINC01234 Functions as a Competing Endogenous RNA to Regulate CBFB Expression by Sponging miR-204-5p in Gastric Cancer.
    Chen X; Chen Z; Yu S; Nie F; Yan S; Ma P; Chen Q; Wei C; Fu H; Xu T; Ren S; Sun M; Wang Z
    Clin Cancer Res; 2018 Apr; 24(8):2002-2014. PubMed ID: 29386218
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.